USPTO trademark

ALIBREX

Under examinationUSPTOWord markClass 5Class 42Class 44

"ALIBREX" is a word mark owned by Onecell Diagnostics, Inc., filed at the USPTO on September 16, 2026. It is under examination and covers classes 5, 42 and 44.

Get this data via the API
Official USPTO record
ALIBREX trademark as filed
As filed with the USPTO
Status
Under examination
Since September 16, 2026
Filed
September 16, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50111821
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns ALIBREX

The owner and representative on file with the office.

Owner

Onecell Diagnostics, Inc.

Cupertino, United States

Representative

Bryan Zerhusen

Cantor Colburn LLP

Goods and services

What the mark covers

The products and services ALIBREX is filed for, grouped by Nice class.

  • Medical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagents and assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy

  • Medical and scientific research in the field of medical diagnostic assays and clinical testing services for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy

  • Medical testing for diagnostic or treatment purposes, namely, for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About ALIBREX

Who owns the trademark "ALIBREX"?

The USPTO trademark "ALIBREX" (application 50111821) is owned by Onecell Diagnostics, Inc.

What is the status of "ALIBREX"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ALIBREX and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0af7f-1e9b-702b-8fc5-484e70873617
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0af7f-1e9b-702b-8fc5-484e70873617",
  "object": "trademark",
  "mark_text": "ALIBREX",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50111821",
  "filing_date": "2026-09-16",
  "nice_classes": [
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "ONECELL DIAGNOSTICS, INC.",
      "entity_id": null
    }
  ]
}